These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32088858)

  • 61. SARS-CoV-2: characteristics and current advances in research.
    Yang Y; Xiao Z; Ye K; He X; Sun B; Qin Z; Yu J; Yao J; Wu Q; Bao Z; Zhao W
    Virol J; 2020 Jul; 17(1):117. PubMed ID: 32727485
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology.
    Dal Moro F; Livi U
    Clin Immunol; 2020 May; 214():108414. PubMed ID: 32272196
    [No Abstract]   [Full Text] [Related]  

  • 63. COVID-19 update: Covid-19-associated coagulopathy.
    Becker RC
    J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
    [No Abstract]   [Full Text] [Related]  

  • 64. COVID-19 Trials and Tribulations by Rebecca Gliksman MD MPH.
    Gliksman R
    J Occup Environ Med; 2020 Sep; 62(9):e542. PubMed ID: 32890229
    [No Abstract]   [Full Text] [Related]  

  • 65. Favipiravir, an antiviral for COVID-19?
    Coomes EA; Haghbayan H
    J Antimicrob Chemother; 2020 Jul; 75(7):2013-2014. PubMed ID: 32417899
    [No Abstract]   [Full Text] [Related]  

  • 66. [Challenges for psychotropics in the context of the SARS-Cov-2 pandemic].
    Javelot H; Llorca PM; Meyer G; Fossati P; Haffen E
    Encephale; 2020 Jun; 46(3S):S116-S118. PubMed ID: 32360037
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A global treatments for coronaviruses including COVID-19.
    Yousefi B; Valizadeh S; Ghaffari H; Vahedi A; Karbalaei M; Eslami M
    J Cell Physiol; 2020 Dec; 235(12):9133-9142. PubMed ID: 32394467
    [TBL] [Abstract][Full Text] [Related]  

  • 68. SnapShot: COVID-19.
    Oberfeld B; Achanta A; Carpenter K; Chen P; Gilette NM; Langat P; Said JT; Schiff AE; Zhou AS; Barczak AK; Pillai S
    Cell; 2020 May; 181(4):954-954.e1. PubMed ID: 32413300
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antivirals for COVID-19 and Breastfeeding.
    Anderson PO
    Breastfeed Med; 2020 Oct; 15(10):605-607. PubMed ID: 32936682
    [No Abstract]   [Full Text] [Related]  

  • 70. Interactions of recommended COVID-19 drugs with commonly used psychotropics.
    Chatterjee SS; Malathesh BC; Das S; Singh OP
    Asian J Psychiatr; 2020 Aug; 52():102173. PubMed ID: 32446195
    [No Abstract]   [Full Text] [Related]  

  • 71. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

  • 72. Photobiomodulation and Antiviral Photodynamic Therapy as a Possible Novel Approach in COVID-19 Management.
    Fekrazad R
    Photobiomodul Photomed Laser Surg; 2020 May; 38(5):255-257. PubMed ID: 32326830
    [No Abstract]   [Full Text] [Related]  

  • 73. COVID-19: a new challenge for human beings.
    Yang P; Wang X
    Cell Mol Immunol; 2020 May; 17(5):555-557. PubMed ID: 32235915
    [No Abstract]   [Full Text] [Related]  

  • 74. Current Perspective of Antiviral Strategies against COVID-19.
    Ahidjo BA; Loe MWC; Ng YL; Mok CK; Chu JJH
    ACS Infect Dis; 2020 Jul; 6(7):1624-1634. PubMed ID: 32485102
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Why not consider an endothelin receptor antagonist against SARS-CoV-2?
    Javor S; Salsano A
    Med Hypotheses; 2020 Aug; 141():109792. PubMed ID: 32361169
    [No Abstract]   [Full Text] [Related]  

  • 76. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
    Li X; Zai J; Zhao Q; Nie Q; Li Y; Foley BT; Chaillon A
    J Med Virol; 2020 Jun; 92(6):602-611. PubMed ID: 32104911
    [TBL] [Abstract][Full Text] [Related]  

  • 77. COVID-19: Small-Molecule Clinical Trials Landscape.
    Ferreira LLG; Andricopulo AD
    Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
    [No Abstract]   [Full Text] [Related]  

  • 78. Evaluation of Potential Therapeutic Options for COVID-19.
    Austin D; Okour M
    J Clin Pharmacol; 2020 Aug; 60(8):976-977. PubMed ID: 32469418
    [No Abstract]   [Full Text] [Related]  

  • 79. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.
    Yang Y; Peng F; Wang R; Yange M; Guan K; Jiang T; Xu G; Sun J; Chang C
    J Autoimmun; 2020 May; 109():102434. PubMed ID: 32143990
    [TBL] [Abstract][Full Text] [Related]  

  • 80. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.